Immunome management announced plans to present at a conference on September 3, 2025.
2 reports, 2 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immunome management announced plans to present at a conference on September 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Immunome management scheduled to present at a conference.1 source
Immunome is facing market headwinds and expected to lag industry growth.1 source
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Business WireImmunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference BOTHELL, Wash., September 03, 2025--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused
- Simply Wall St.Growth Investors: Industry Analysts Just Upgraded Their Immunome, Inc. (NASDAQ:IMNM) Revenue Forecasts By 73% Immunome, Inc. (NASDAQ:IMNM) shareholders will have a reason to smile today, with the ana